TTF1 control of LncRNA synthesis delineates a tumor suppressor pathway directly regulating the ribosomal RNA genes
Journal of Cellular Physiology · 2024-08 · 239 (8)
DOI: 10.1002/jcp.31303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 19.05.2024. Verfasst von Dany S Sibai und 6 weiteren Autor:innen. Beteiligte Einrichtung: St-Patrick Research Group in Basic Oncology, Cancer Division of the Quebec University Hospital Research Centre, Laval University, Quebec City, Quebec…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Promoter Regions, Genetic, Transcription Factors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), Fonds de Recherche du Québec - Santé (FRQS).
Abstract (Originalsprache)
The tumor suppressor p14/19ARF regulates ribosomal RNA (rRNA) synthesis by controlling the nucleolar localization of Transcription Termination Factor 1 (TTF1). However, the role played by TTF1 in regulating the rRNA genes and in potentially controlling growth has remained unclear. We now show that TTF1 expression regulates cell growth by determining the cellular complement of ribosomes. Unexpectedly, it achieves this by acting as a “roadblock” to synthesis of the noncoding LncRNA and pRNA that we show are generated from the “Spacer Promoter” duplications present upstream of the 47S pre‐rRNA promoter on the mouse and human ribosomal RNA genes. Unexpectedly, the endogenous generation of these noncoding RNAs does not induce CpG methylation or gene silencing. Rather, it acts in cis to suppress 47S preinitiation complex formation and hence de novo pre‐rRNA synthesis by a mechanism reminiscent of promoter interference or occlusion. Taken together, our data delineate a pathway from p19ARF to cell growth suppression via the regulation of ribosome biogenesis by noncoding RNAs and validate a key cellular growth law in mammalian cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St-Patrick Research Group in Basic Oncology, Cancer Division of the Quebec University Hospital Research Centre, Laval University, Quebec City, Quebec, Canada.
- Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.
- Cancer Research Centre, Laval University, Quebec City, Quebec, Canada.
- Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Tom Moss
Förderung
- Canadian Institutes of Health Research (CIHR)
- Fonds de Recherche du Québec - Santé (FRQS)
Zitieren
APA
Sibai, D. S., Tremblay, M. G., Lessard, F., Tav, C., Sabourin-Félix, M., Robinson, M., & Moss, T. (2024). TTF1 control of LncRNA synthesis delineates a tumor suppressor pathway directly regulating the ribosomal RNA genes. Journal of Cellular Physiology, 239(8). https://doi.org/10.1002/jcp.31303
Vancouver
Sibai DS, Tremblay MG, Lessard F, Tav C, Sabourin-Félix M, Robinson M, et al. TTF1 control of LncRNA synthesis delineates a tumor suppressor pathway directly regulating the ribosomal RNA genes. Journal of Cellular Physiology. 2024;239(8). doi:10.1002/jcp.31303
BibTeX
@article{Sibai2024,
author = {Sibai, Dany S and Tremblay, Michel G and Lessard, Frédéric and Tav, Christophe and Sabourin-Félix, Marianne and Robinson, Mark and Moss, Tom},
title = {TTF1 control of LncRNA synthesis delineates a tumor suppressor pathway directly regulating the ribosomal RNA genes},
journal = {Journal of Cellular Physiology},
year = {2024},
volume = {239},
number = {8},
doi = {10.1002/jcp.31303}
}
EUVIMED